Lung Cancer News

A centralized counseling and shared decision-making visit impacts patient knowledge of eligibility criteria for lung cancer screening, as well as the benefits and harms of screening with low radiation dose chest CT scan, according to study results.

The use of stereotactic radiosurgery followed by epidermal growth factor receptor tyrosine kinase inhibitors resulted in longer OS than other strategies for patients with EGFR–mutated non–small cell lung cancer who developed brain metastases, according to a multi-institutional analysis published in Journal of Clinical Oncology.

Genomic alterations appeared similar in black and white patients with lung adenocarcinoma and lung squamous cell carcinoma, according to results of a genomic cohort study.

Researchers observed lower levels of selected carcinogens and toxins among former smokers who only used nicotine replacement therapies or e-cigarettes long-term compared to people who had used combustible cigarettes long-term, according to recent findings.

Therapies introduced in the mid-2000s to treat advanced-stage non–small cell lung cancer — including pemetrexed, erlotinib and bevacizumab — are associated with a 1.5-month survival increase and approximately an $8,000 increase in outpatient spending per patient, according to a 12-year study published in Journal of Clinical Oncology.

A national survey showed the majority of Americans aged younger than 35 years believe electronic cigarettes are not as harmful to the lungs as traditional cigarettes.

Two new studies published in JAMA Internal Medicine found that there was a lack of uptake of lung cancer screening programs despite their established effectiveness.

Augustine M.K. Choi, MD, has been named Stephen and Suzanne Weiss dean of Weill Cornell Medicine.

Medicare beneficiaries diagnosed with early-stage non–small cell lung cancer endure a high treatment burden, which appeared to vary by type of treatment, according to results of a retrospective cohort study.

Families of patients with lung cancer or colorectal cancer reported that their family member had improved end-of-life care and better symptom relief before death while in hospice care, according to published findings in the Journal of Clinical Oncology.